156 related articles for article (PubMed ID: 32341061)
1. Endogenous CD83 Expression in CD4
Liedtke K; Alter C; Günther A; Hövelmeyer N; Klopfleisch R; Naumann R; Wunderlich FT; Buer J; Westendorf AM; Hansen W
J Immunol; 2020 Jun; 204(12):3217-3226. PubMed ID: 32341061
[TBL] [Abstract][Full Text] [Related]
2. CD83 expression in CD4+ T cells modulates inflammation and autoimmunity.
Reinwald S; Wiethe C; Westendorf AM; Breloer M; Probst-Kepper M; Fleischer B; Steinkasserer A; Buer J; Hansen W
J Immunol; 2008 May; 180(9):5890-7. PubMed ID: 18424708
[TBL] [Abstract][Full Text] [Related]
3. CD83 Antibody Inhibits Human B Cell Responses to Antigen as well as Dendritic Cell-Mediated CD4 T Cell Responses.
Wong KY; Baron R; Seldon TA; Jones ML; Rice AM; Munster DJ
J Immunol; 2018 May; 200(10):3383-3396. PubMed ID: 29643191
[TBL] [Abstract][Full Text] [Related]
4. Endogenous Expression of the Human CD83 Attenuates EAE Symptoms in Humanized Transgenic Mice and Increases the Activity of Regulatory T Cells.
Zinser E; Naumann R; Wild AB; Michalski J; Deinzer A; Stich L; Kuhnt C; Steinkasserer A; Knippertz I
Front Immunol; 2019; 10():1442. PubMed ID: 31293592
[TBL] [Abstract][Full Text] [Related]
5. CD83 orchestrates immunity toward self and non-self in dendritic cells.
Wild AB; Krzyzak L; Peckert K; Stich L; Kuhnt C; Butterhof A; Seitz C; Mattner J; Grüner N; Gänsbauer M; Purtak M; Soulat D; Winkler TH; Nitschke L; Zinser E; Steinkasserer A
JCI Insight; 2019 Oct; 4(20):. PubMed ID: 31527313
[TBL] [Abstract][Full Text] [Related]
6. Enhanced activation of CD83-positive T cells.
Wolenski M; Cramer SO; Ehrlich S; Steeg C; Fleischer B; von Bonin A
Scand J Immunol; 2003 Sep; 58(3):306-11. PubMed ID: 12950676
[TBL] [Abstract][Full Text] [Related]
7. CD83 expression is a sensitive marker of activation required for B cell and CD4+ T cell longevity in vivo.
Prazma CM; Yazawa N; Fujimoto Y; Fujimoto M; Tedder TF
J Immunol; 2007 Oct; 179(7):4550-62. PubMed ID: 17878352
[TBL] [Abstract][Full Text] [Related]
8. Continuous expression of CD83 on activated human CD4⁺ T cells is correlated with their differentiation into induced regulatory T cells.
Chen L; Guan S; Zhou Q; Sheng S; Zhong F; Wang Q
Mol Med Rep; 2015 Sep; 12(3):3309-3314. PubMed ID: 25997495
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cells and T-cell-derived IL-10 interfere with effective anti-cytomegalovirus immune response.
Jost NH; Abel S; Hutzler M; Sparwasser T; Zimmermann A; Roers A; Müller W; Klopfleisch R; Hengel H; Westendorf AM; Buer J; Hansen W
Immunol Cell Biol; 2014 Nov; 92(10):860-71. PubMed ID: 25070242
[TBL] [Abstract][Full Text] [Related]
10. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells.
Carter NA; Vasconcellos R; Rosser EC; Tulone C; Muñoz-Suano A; Kamanaka M; Ehrenstein MR; Flavell RA; Mauri C
J Immunol; 2011 May; 186(10):5569-79. PubMed ID: 21464089
[TBL] [Abstract][Full Text] [Related]
11. Role of interleukin-1beta in activating the CD11c(high) CD45RB- dendritic cell subset and priming Leishmania amazonensis-specific CD4+ T cells in vitro and in vivo.
Xin L; Li Y; Soong L
Infect Immun; 2007 Oct; 75(10):5018-26. PubMed ID: 17682041
[TBL] [Abstract][Full Text] [Related]
12. CD83: a regulatory molecule of the immune system with great potential for therapeutic application.
Fujimoto Y; Tedder TF
J Med Dent Sci; 2006 Jun; 53(2):85-91. PubMed ID: 16913569
[TBL] [Abstract][Full Text] [Related]
13. Loxoribine, a selective Toll-like receptor 7 agonist, induces maturation of human monocyte-derived dendritic cells and stimulates their Th-1- and Th-17-polarizing capability.
Dzopalic T; Dragicevic A; Vasilijic S; Vucevic D; Majstorovic I; Bozic B; Balint B; Colic M
Int Immunopharmacol; 2010 Nov; 10(11):1428-33. PubMed ID: 20817120
[TBL] [Abstract][Full Text] [Related]
14. Host-dependent control of early regulatory and effector T-cell differentiation underlies the genetic susceptibility of RAG2-deficient mouse strains to transfer colitis.
Valatas V; He J; Rivollier A; Kolios G; Kitamura K; Kelsall BL
Mucosal Immunol; 2013 May; 6(3):601-11. PubMed ID: 23149660
[TBL] [Abstract][Full Text] [Related]
15. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells.
Jonuleit H; Schmitt E; Schuler G; Knop J; Enk AH
J Exp Med; 2000 Nov; 192(9):1213-22. PubMed ID: 11067871
[TBL] [Abstract][Full Text] [Related]
16. Impaired Progesterone-Responsiveness of CD11c
Thiele K; Hierweger AM; Riquelme JIA; Solano ME; Lydon JP; Arck PC
Front Endocrinol (Lausanne); 2019; 10():96. PubMed ID: 30858825
[TBL] [Abstract][Full Text] [Related]
17. Transgenic expression of a CD83-immunoglobulin fusion protein impairs the development of immune-competent CD4-positive T cells.
Lüthje K; Cramer SO; Ehrlich S; Veit A; Steeg C; Fleischer B; Bonin Av; Breloer M
Eur J Immunol; 2006 Aug; 36(8):2035-45. PubMed ID: 16841299
[TBL] [Abstract][Full Text] [Related]
18. Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease.
Shrestha B; Walton K; Reff J; Sagatys EM; Tu N; Boucher J; Li G; Ghafoor T; Felices M; Miller JS; Pidala J; Blazar BR; Anasetti C; Betts BC; Davila ML
J Clin Invest; 2020 Sep; 130(9):4652-4662. PubMed ID: 32437331
[TBL] [Abstract][Full Text] [Related]
19. Role of CD83 in the immunomodulation of dendritic cells.
Lechmann M; Zinser E; Golka A; Steinkasserer A
Int Arch Allergy Immunol; 2002 Oct; 129(2):113-8. PubMed ID: 12403928
[TBL] [Abstract][Full Text] [Related]
20. CD83 expression influences CD4+ T cell development in the thymus.
Fujimoto Y; Tu L; Miller AS; Bock C; Fujimoto M; Doyle C; Steeber DA; Tedder TF
Cell; 2002 Mar; 108(6):755-67. PubMed ID: 11955430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
